2014
DOI: 10.1016/j.clinthera.2014.04.019
|View full text |Cite
|
Sign up to set email alerts
|

Exosomes as Immunotheranostic Nanoparticles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
68
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 89 publications
(69 citation statements)
references
References 54 publications
1
68
0
Order By: Relevance
“…They are also involved in transferring genetic materials, and modulation of immune response. Evidence indicates that they can be used as not only therapeutic agents targeted against disease but also diagnostic biomarkers for pathologic conditions [79]. Actually, NP-induced exosomes are signaling mediators, which provoke the activation of T helper cell type 1 and inflammatory responses [80].…”
Section: Extracellular Matrixmentioning
confidence: 99%
“…They are also involved in transferring genetic materials, and modulation of immune response. Evidence indicates that they can be used as not only therapeutic agents targeted against disease but also diagnostic biomarkers for pathologic conditions [79]. Actually, NP-induced exosomes are signaling mediators, which provoke the activation of T helper cell type 1 and inflammatory responses [80].…”
Section: Extracellular Matrixmentioning
confidence: 99%
“…Exosomes are uniquely suited for drug or gene delivery because they are naturally biocompatible, stable while circulating in the blood, and capable of crossing the blood brain barrier [ 113 ]. Dendritic cell-derived exosomes (dexosomes) have been successfully engineered to target helper T cells to stimulate cytotoxic T cell proliferation, influence T cell differentiation, and create an anti-tumor environment [ 114 ].…”
Section: Applications Of Exosomes To Cancer Diagnostics and Therapymentioning
confidence: 99%
“…Likewise, dexosomes generated only grade 1–2 adverse effects and were able to stabilize disease during a phase I clinical trial for non-small cell lung cancer patients [ 117 ]. Reviews have been recently published for exosomes as cancer vaccines [ 113 ] and dexosome immunotherapy [ 118 ].…”
Section: Applications Of Exosomes To Cancer Diagnostics and Therapymentioning
confidence: 99%
“…The extracellular vesicles produced by SFTS virus NSs-expressing cells and SFTS virus-infected cells displayed markers characteristic of exosomes, such as being positive for the tetraspanin CD63, a widely used exosome marker (46). Interestingly, we also found that the extracellular vesicles preferentially contain LC3-I rather than LC3-II.…”
Section: Discussionmentioning
confidence: 50%